Frazier Life Sciences XI, L.P.
SEC CIK 1911592 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATTO | Attovia Therapeutics, Inc. | 10% | 5.57M | $10.00M | — | 2 | 2026-08-06 | 2026-08-06 |
Most active insiders at ATTO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALSH COLIN | Dir | $20.57M | $4.50M |
| 2 | Redmile Group, LLC | 10% | $10.20M | — |
| 3 | Frazier Life Sciences XI, L.P. | 10% | $10.00M | — |
| 4 | venBio Global Strategic Fund IV, L.P. | 10% | $6.50M | — |
| 5 | Sanofi | 10% | $5.10M | — |
| 6 | Deep Track Biotechnology Master Fund, Ltd. | 10% | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-06 17:35 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Frazier Life Sciences XI, L.P. | 10% | C - Cnv Deriv | — | +5.49M | 5.57M | +7,287% | — |
| D | 2026-08-06 17:35 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Frazier Life Sciences XI, L.P. | 10% | P - Purchase | $17.00 | +588.2K | 6.15M | +11% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations